Skip to main content

Advertisement

Log in

Ischemic stroke associated with immune thrombocytopenia: lesion patterns and characteristics

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Although the patients with immune thrombocytopenia (ITP) have a very low platelet count, which usually causes hemorrhagic complications, they occasionally experience ischemic stroke. However, the mechanism underlying ITP-related ischemic stroke (ITP-IS) has not been fully clarified. We aim to elucidate the ITP-IS mechanism by analyzing the ischemic lesion patterns and clinical characteristics. We assessed consecutive first-ever acute ischemic stroke (AIS) patients with ITP admitted to Seoul National University Hospital between October 2002 and October 2011. The stroke lesion pattern and clinical characteristics of ITP-IS patients were analyzed. Of the 2,185 patients with first-ever AIS, seven patients (4 women) with ITP-IS were identified. Of these seven patients, 3 (43 %) who were classified as undetermined stroke etiology indicated an embolic stroke pattern, and had no remarkable atherosclerotic risk factors, no steno-occlusive lesions in their relevant artery, and no cardioembolic etiologies or conditions causing secondary ITP. Moreover, compared with the patients without ITP, the patients with ITP were younger and had lower platelet counts. Thus, we noted that ITP is a rare cause of ischemic stroke, which primarily occurs due to the development of a thromboembolism in the brain. We believe that this paradoxical mechanism of ITP-associated thrombus formation requires further investigation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Cortelazzo S, Finazzi G, Buelli M, Molteni A, Viero P, Barbui T (1991) High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura. Blood 77(1):31–33

    CAS  PubMed  Google Scholar 

  2. Sarpatwari A, Bennett D, Logie JW, Shukla A, Beach KJ, Newland AC, Sanderson S, Provan D (2010) Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database. Haematologica 95(7):1167–1175

    Article  PubMed Central  PubMed  Google Scholar 

  3. Phan TG, Owen R (2011) Paradoxical ischemic stroke in the setting of idiopathic thrombocytopenic purpura. Intern Med J 41(8):643–644

    Article  CAS  PubMed  Google Scholar 

  4. Theeler BJ, Ney JP (2008) A patient with idiopathic thrombocytopenic purpura presenting with an acute ischemic stroke. J Stroke Cerebrovasc Dis 17(4):244–245

    Article  PubMed  Google Scholar 

  5. Wessels T, Wessels C, Ellsiepen A, Reuter I, Trittmacher S, Stolz E, Jauss M (2006) Contribution of diffusion-weighted imaging in determination of stroke etiology. AJNR Am J Neuroradiol 27(1):35–39

    CAS  PubMed  Google Scholar 

  6. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24(1):35–41

    Article  PubMed  Google Scholar 

  7. Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA (2011) The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 117(16):4190–4207

    Article  CAS  PubMed  Google Scholar 

  8. Cines DB, Bussel JB, Liebman HA, Prak ETL (2009) The ITP syndrome: pathogenic and clinical diversity. Blood 113(26):6511–6521

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Katz U, Shoenfeld Y (2005) Review: intravenous immunoglobulin therapy and thromboembolic complications. Lupus 14(10):802–808

    Article  CAS  PubMed  Google Scholar 

  10. Sims PJ, Faioni EM, Wiedmer T, Shattil SJ (1988) Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 263(34):18205–18212

    CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Seung-Hoon Lee.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 47 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Park, HK., Lee, SH. Ischemic stroke associated with immune thrombocytopenia: lesion patterns and characteristics. Neurol Sci 35, 1801–1806 (2014). https://doi.org/10.1007/s10072-014-1843-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-014-1843-0

Keywords

Navigation